GlassScriptPhysician profile
Amberly C Paradoa
NPI 1962400713
$6,059.45
in general payments reported to CMS, 2019-2025
32 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $420 · 2021: $1,825 · 2022: $621 · 2023: $2,206 · 2024: $368 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,268.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $1,567.20 | 2020-2023 | Ceramentbone Void Filler |
| Southern Edge Orthopaedics, INC. | $1,224.72 | 2021-2023 | |
| Organogenesis INC. | $425.08 | 2019-2024 | Puraply |
| Stryker Corporation | $360.72 | 2021-2025 | Ortholoc 2 Lapifuse, Ortholoc 3di Crosscheck, N/A |
| Janssen Biotech, INC. | $238.59 | 2019-2022 | |
| Kerecis Limited | $229.39 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $202.05 | 2019-2025 | |
| Paragon 28, INC. | $189.92 | 2022-2023 | Portfolio |
| Horizon Therapeutics Plc | $157.93 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $135.48 | 2020-2022 | |
| Boston Scientific Corporation | $128.57 | 2024 | |
| Smith+Nephew, INC. | $128.01 | 2021-2022 | |
| Amgen INC. | $123.00 | 2019-2022 | |
| Anika Therapeutics, INC. | $112.49 | 2022 | |
| Medtronic, INC. | $108.99 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $101.67 | 2025 | |
| Medline Industries LP | $87.62 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $85.80 | 2023 | |
| Kci USA, INC. | $77.02 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $60.04 | 2022-2024 | Delstrigo, Pifeltro |
| Next Science LLC | $41.13 | 2023 | Surgx, Xperience, Blastx |
| Cumberland Pharmaceuticals, INC. | $38.36 | 2019-2020 | |
| Abbvie INC. | $35.95 | 2021-2022 | |
| Depuy Synthes Sales INC. | $32.26 | 2023 | Hammerlock, Na |
| Stability Biologics, LLC | $31.74 | 2022 | |
| Lifenet Health | $24.30 | 2023 | |
| Arthrosurface Incorporated | $21.96 | 2019 | |
| Daiichi Sankyo INC. | $21.66 | 2019 | |
| Zimmer Biomet Holdings, INC. | $21.44 | 2021 | |
| Merz North America, INC. | $18.84 | 2024 | |
| Melinta Therapeutics, LLC | $16.47 | 2022 | |
| Grt US Holding, INC. | $11.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amberly Paradoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.